Bachem Holding AG (BANB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bachem Holding AG (BANB) has a cash flow conversion efficiency ratio of 0.127x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF185.50 Million ≈ $234.52 Million USD) by net assets (CHF1.46 Billion ≈ $1.84 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bachem Holding AG net asset quality index to measure how much of total assets are equity-financed.
Bachem Holding AG - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Bachem Holding AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Bachem Holding AG cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Bachem Holding AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bachem Holding AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Black Hills Corporation
NYSE:BKH
|
0.044x |
|
Gerdau SA ADR
NYSE:GGB
|
0.028x |
|
Qingdao TGOOD Electric Co Ltd
SHE:300001
|
0.107x |
|
Duolingo Inc
NASDAQ:DUOL
|
0.108x |
|
SmartSens Technology (Shanghai) Co. Ltd. A
SHG:688213
|
N/A |
|
Vishal Mega Mart Ord Shs
NSE:VMM
|
0.107x |
|
Amentum Holdings Inc.
NYSE:AMTM
|
-0.029x |
|
Goldenmax International Technology Ltd
SHE:002636
|
-0.025x |
Annual Cash Flow Conversion Efficiency for Bachem Holding AG (2002–2025)
The table below shows the annual cash flow conversion efficiency of Bachem Holding AG from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see Bachem Holding AG (BANB) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CHF1.46 Billion ≈ $1.84 Billion |
CHF271.36 Million ≈ $343.07 Million |
0.186x | +76.91% |
| 2024-12-31 | CHF1.39 Billion ≈ $1.76 Billion |
CHF146.32 Million ≈ $184.99 Million |
0.105x | -44.41% |
| 2023-12-31 | CHF1.32 Billion ≈ $1.67 Billion |
CHF249.86 Million ≈ $315.90 Million |
0.189x | +138.88% |
| 2022-12-31 | CHF1.17 Billion ≈ $1.48 Billion |
CHF92.65 Million ≈ $117.13 Million |
0.079x | -8.98% |
| 2021-12-31 | CHF1.12 Billion ≈ $1.42 Billion |
CHF97.56 Million ≈ $123.34 Million |
0.087x | -64.01% |
| 2020-12-31 | CHF475.71 Million ≈ $601.43 Million |
CHF115.04 Million ≈ $145.44 Million |
0.242x | +68.51% |
| 2019-12-31 | CHF447.82 Million ≈ $566.16 Million |
CHF64.27 Million ≈ $81.25 Million |
0.144x | +113.92% |
| 2018-12-31 | CHF384.21 Million ≈ $485.75 Million |
CHF25.78 Million ≈ $32.59 Million |
0.067x | -31.19% |
| 2017-12-31 | CHF374.17 Million ≈ $473.05 Million |
CHF36.48 Million ≈ $46.12 Million |
0.097x | -11.85% |
| 2016-12-31 | CHF365.36 Million ≈ $461.92 Million |
CHF40.41 Million ≈ $51.09 Million |
0.111x | -36.38% |
| 2015-12-31 | CHF353.36 Million ≈ $446.75 Million |
CHF61.43 Million ≈ $77.67 Million |
0.174x | +28.55% |
| 2014-12-31 | CHF349.13 Million ≈ $441.40 Million |
CHF47.22 Million ≈ $59.70 Million |
0.135x | -7.57% |
| 2013-12-31 | CHF336.44 Million ≈ $425.35 Million |
CHF49.23 Million ≈ $62.24 Million |
0.146x | +29.70% |
| 2012-12-31 | CHF326.82 Million ≈ $413.19 Million |
CHF36.87 Million ≈ $46.61 Million |
0.113x | +53.09% |
| 2011-12-31 | CHF333.94 Million ≈ $422.19 Million |
CHF24.61 Million ≈ $31.11 Million |
0.074x | -30.57% |
| 2010-12-31 | CHF359.04 Million ≈ $453.92 Million |
CHF38.11 Million ≈ $48.18 Million |
0.106x | -6.83% |
| 2009-12-31 | CHF376.11 Million ≈ $475.50 Million |
CHF42.85 Million ≈ $54.17 Million |
0.114x | +8.81% |
| 2008-12-31 | CHF375.15 Million ≈ $474.30 Million |
CHF39.28 Million ≈ $49.66 Million |
0.105x | -51.81% |
| 2007-12-31 | CHF359.38 Million ≈ $454.35 Million |
CHF78.07 Million ≈ $98.70 Million |
0.217x | +110.59% |
| 2006-12-31 | CHF389.21 Million ≈ $492.07 Million |
CHF40.15 Million ≈ $50.76 Million |
0.103x | +39.27% |
| 2005-12-31 | CHF370.23 Million ≈ $468.07 Million |
CHF27.42 Million ≈ $34.67 Million |
0.074x | -49.88% |
| 2004-12-31 | CHF337.11 Million ≈ $426.20 Million |
CHF49.82 Million ≈ $62.98 Million |
0.148x | +34.89% |
| 2003-12-31 | CHF324.09 Million ≈ $409.74 Million |
CHF35.51 Million ≈ $44.89 Million |
0.110x | -9.56% |
| 2002-12-31 | CHF310.77 Million ≈ $392.89 Million |
CHF37.64 Million ≈ $47.59 Million |
0.121x | -- |
About Bachem Holding AG
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commerci… Read more